The specificity of the PC-3 tumor uptake (GRPR-positive) was further confirmed by the significantly lower uptake of the radioligand in the DU-145 tumors (GRPR-negative) that was at the same level as the GRPR-blocked group (Figure 6). The gene discussed is GRPR; the disease is neoplasm.